News

Dr. Martin Gershon to Inspire at Upcoming Investor Capital Expo

Dr. Martin Gershon to Inspire at Upcoming Investor Capital Expo

Dr. Martin Gershon to Inspire at Upcoming Investor Capital Expo

Keiretsu Forum, the largest and most active accredited angel investor network, is proud to feature Dr. Martin Gershon as the keynote speaker for the 2024 Investor Capital Expo. This event stands as a significant milestone for all engaged in early-stage investments.

Introducing Dr. Martin Gershon

Dr. Gershon, who is the Managing Partner and Chief Investment Officer of Endeavor Venture Funds and Endeavor Venture Studio, brings extensive expertise in healthcare innovation and venture capital. With over two decades of experience, he has led the charge on more than 100 investments, achieving 24 successful exits, thereby establishing himself as a pivotal player in healthcare investment.

A Visionary Leader

His remarkable leadership at Endeavor showcases an unwavering commitment to fostering innovation. Recently, he has focused on harnessing the potential of artificial intelligence (AI) in drug discovery, a field that is experiencing rapid advancements and creating endless possibilities.

Recognitions and Contributions

Dr. Gershon has been recognized as a 'Top Voice' in Venture Capital and Entrepreneurship on LinkedIn, and has received accolades as one of the Top 100 Healthcare Industry Leaders by Standard & Poor's. His insights are highly sought after, making him a notable speaker at industry events.

Keynote Address Details

His keynote presentation will be titled "Pioneering Healthcare Innovation: Investment Strategies in AI Drug Discovery." During his address, Dr. Gershon will share his vast knowledge regarding the significant impact of AI on drug development. He aims to cover:

  • Investment Opportunities: Diving into high-growth potential in AI-driven drug discovery.
  • Strategic Insights: Gaining an understanding of how AI accelerates the crafting of novel therapeutics.
  • Future Trends: Shedding light on innovations that will shape the life sciences and healthcare industries.

About the Investor Capital Expo

The Investor Capital Expo is a primary venue for angel investors, venture capitalists, and entrepreneurs to connect and collaborate. This prominent gathering is focused on showcasing startups that have undergone rigorous due diligence through the Keiretsu Forum, providing investors with invaluable networking opportunities and insights from industry leaders.

A Platform for Growth

Keiretsu Forum is dedicated to enriching the early-stage innovation landscape by connecting accredited investors with emerging companies across various sectors. The Expo serves not only as a networking opportunity, but also as a platform where visionary entrepreneurs can shine.

Building Strong Relationships

The relationship between Keiretsu Forum and Endeavor, underpinned by a shared vision, has forged a pathway for greater access to remarkable entrepreneurs and strategic partnerships. This collaboration is aimed at fostering sustainable growth in the startup ecosystem.

Event Logistics

The Investor Capital Expo is set to take place on October 31, 2024.

  • Date: October 31, 2024
  • Time: 8:00 AM – 6:00 PM EDT
  • Location: Convene City View, 30 S 17th St, Philadelphia, PA

Invitation to Investors

Accredited angel investors are encouraged to register for this exclusive event. Attendees will have the unique opportunity to engage with the next wave of industry disruptors, gaining insights from prominent figures in healthcare innovation.

About Keiretsu Forum

Keiretsu Forum, with over 2000 accredited investors across North America and internationally, stands as the world's largest private equity investment network. In its 23-year history, it has invested over $1 billion in a multitude of early-stage companies.

A Diverse Portfolio

The portfolio features a vast array of entrepreneurs and companies spanning technology, life sciences, fintech, and more, representing a dynamic and diverse marketplace.

Insights into Dr. Martin Gershon

Throughout his career, Dr. Gershon has demonstrated a commitment to healthcare and life sciences innovation. He has connected startups with Fortune 500 partnerships, providing invaluable strategic growth solutions.

Academic Credentials and Influence

His academic journey has taken him through prestigious institutions, including training in neuroscience and oncology. His expertise has led to significant advisory roles with influential organizations and initiatives.

For Media Inquiries

For any media-related questions, please contact:

Cindi Sutera
AMS Communications
CindiS@AMSCommunications.net
610-613-2773

Frequently Asked Questions

What is the focus of Dr. Gershon's keynote address?

Dr. Gershon will discuss investment strategies in AI drug discovery and the transformative impact AI has on drug development.

When and where will the Investor Capital Expo be held?

The Expo will take place on October 31, 2024, at Convene City View, Philadelphia.

Who can attend the Investor Capital Expo?

The event is geared towards accredited angel investors, venture capitalists, and entrepreneurs interested in networking and investment opportunities.

Why is Dr. Gershon a significant keynote speaker?

His extensive experience in life sciences and healthcare startups, combined with his leadership in AI innovation, makes him an ideal voice in the investment space.

How does Keiretsu Forum support early-stage companies?

Keiretsu Forum provides access to funding, guidance, and networking opportunities for startups, helping them navigate their growth journeys.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 244

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 385

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 309

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 185

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 322

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 324

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 393

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 273

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 234

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 430

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading

Top 5 Most Recently Viewed Articles

Banco Comercial Português Highlights Positive Share Buy-Back Activities

Updated Category News Views 137

Banco Comercial Português: An Overview of Recent Developments Banco Comercial Português, S.A., recognized for its pivotal role in the financial sector, has recently shared insights about its Share Buy-Back Programme. This initiative reflects the bank's commitment to enhancing shareholder value while solidifying its market presence. The interim report detailing the...

Continue Reading
How a $1000 Investment in Texas Instruments Transforms Over 15 Years

Updated Category News Views 135

Understanding the Growth of Texas Instruments Investments Texas Instruments (NASDAQ: TXN) has displayed impressive growth over the past 15 years, outpacing the market by an average of 2.3% annually. This translates to a robust average annual return of 14.17%, reflecting this company's strong position in the semiconductor industry. With a market capitalization now standing...

Continue Reading
Bitdeer Technologies Group's Q4 2024 Financial Overview

Updated Category News Views 204

Bitdeer Technologies Group's Financial Results Analysis Bitdeer Technologies Group (NASDAQ: BTDR), a prominent player in blockchain technology and high-performance computing, has recently unveiled its unaudited financial results for the final quarter of 2024. The announcement sheds light on the company's performance, revealing significant shifts in revenue and expenses...

Continue Reading
NodeAI Revolutionizes Lung Cancer Care with AI Solutions

Updated Category News Views 206

NodeAI's Groundbreaking Achievement in Cancer Diagnostics NodeAI, a pioneering startup based in Hamilton, Ontario, has recently garnered attention for its exceptional advancements in lung cancer diagnostics. The company participated in FACIT's annual pitch competition, known as Falcons' Fortunes, and emerged victorious, earning a prestigious award for its innovative...

Continue Reading
Runway Growth Capital Bolsters Leadership with Rovner

Updated Category News Views 72

A New Era for Runway Growth Capital Alright folks, here's the scoop for anyone tracking the moves in the growth lending space: Michael Rovner, with his hefty 30-year career in the financial sector, is now taking on the role of Co-Chief Executive Officer and Co-Chief Investment Officer at Runway Growth Capital. This guy's a veteran, no doubt, having navigated the overlaps...

Continue Reading